234 related articles for article (PubMed ID: 19776133)
1. Hepatoma cell density promotes claudin-1 and scavenger receptor BI expression and hepatitis C virus internalization.
Schwarz AK; Grove J; Hu K; Mee CJ; Balfe P; McKeating JA
J Virol; 2009 Dec; 83(23):12407-14. PubMed ID: 19776133
[TBL] [Abstract][Full Text] [Related]
2. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection.
Tong Y; Zhu Y; Xia X; Liu Y; Feng Y; Hua X; Chen Z; Ding H; Gao L; Wang Y; Feitelson MA; Zhao P; Qi ZT
J Virol; 2011 Mar; 85(6):2793-802. PubMed ID: 21177818
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection of neuroepithelioma cell lines.
Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
[TBL] [Abstract][Full Text] [Related]
4. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.
Ploss A; Evans MJ; Gaysinskaya VA; Panis M; You H; de Jong YP; Rice CM
Nature; 2009 Feb; 457(7231):882-6. PubMed ID: 19182773
[TBL] [Abstract][Full Text] [Related]
5. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection.
Liu S; Yang W; Shen L; Turner JR; Coyne CB; Wang T
J Virol; 2009 Feb; 83(4):2011-4. PubMed ID: 19052094
[TBL] [Abstract][Full Text] [Related]
6. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
[TBL] [Abstract][Full Text] [Related]
7. Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains.
Dreux M; Dao Thi VL; Fresquet J; Guérin M; Julia Z; Verney G; Durantel D; Zoulim F; Lavillette D; Cosset FL; Bartosch B
PLoS Pathog; 2009 Feb; 5(2):e1000310. PubMed ID: 19229312
[TBL] [Abstract][Full Text] [Related]
8. Effect of cell polarization on hepatitis C virus entry.
Mee CJ; Grove J; Harris HJ; Hu K; Balfe P; McKeating JA
J Virol; 2008 Jan; 82(1):461-70. PubMed ID: 17959672
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus receptor expression in normal and diseased liver tissue.
Reynolds GM; Harris HJ; Jennings A; Hu K; Grove J; Lalor PF; Adams DH; Balfe P; Hübscher SG; McKeating JA
Hepatology; 2008 Feb; 47(2):418-27. PubMed ID: 18085708
[TBL] [Abstract][Full Text] [Related]
10. The SR-BI partner PDZK1 facilitates hepatitis C virus entry.
Eyre NS; Drummer HE; Beard MR
PLoS Pathog; 2010 Oct; 6(10):e1001130. PubMed ID: 20949066
[TBL] [Abstract][Full Text] [Related]
11. Single Particle Imaging of Polarized Hepatoma Organoids upon Hepatitis C Virus Infection Reveals an Ordered and Sequential Entry Process.
Baktash Y; Madhav A; Coller KE; Randall G
Cell Host Microbe; 2018 Mar; 23(3):382-394.e5. PubMed ID: 29544098
[TBL] [Abstract][Full Text] [Related]
12. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
[TBL] [Abstract][Full Text] [Related]
13. Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma.
Sekhar V; Pollicino T; Diaz G; Engle RE; Alayli F; Melis M; Kabat J; Tice A; Pomerenke A; Altan-Bonnet N; Zamboni F; Lusso P; Emerson SU; Farci P
PLoS Pathog; 2018 Mar; 14(3):e1006916. PubMed ID: 29538454
[TBL] [Abstract][Full Text] [Related]
14. Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.
Hikosaka K; Noritake H; Kimura W; Sultana N; Sharkar MT; Tagawa Y; Uezato T; Kobayashi Y; Wakita T; Miura N
Biomed Res; 2011 Apr; 32(2):143-50. PubMed ID: 21551950
[TBL] [Abstract][Full Text] [Related]
15. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
J Virol; 2018 May; 92(10):. PubMed ID: 29491159
[TBL] [Abstract][Full Text] [Related]
16. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.
Haid S; Windisch MP; Bartenschlager R; Pietschmann T
J Virol; 2010 Jan; 84(2):964-75. PubMed ID: 19889758
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C Virus Entry: Protein Interactions and Fusion Determinants Governing Productive Hepatocyte Invasion.
Gerold G; Moeller R; Pietschmann T
Cold Spring Harb Perspect Med; 2020 Feb; 10(2):. PubMed ID: 31427285
[TBL] [Abstract][Full Text] [Related]
18. Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.
Mee CJ; Harris HJ; Farquhar MJ; Wilson G; Reynolds G; Davis C; van IJzendoorn SC; Balfe P; McKeating JA
J Virol; 2009 Jun; 83(12):6211-21. PubMed ID: 19357163
[TBL] [Abstract][Full Text] [Related]
19. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
[TBL] [Abstract][Full Text] [Related]
20. Correlation of the tight junction-like distribution of Claudin-1 to the cellular tropism of hepatitis C virus.
Yang W; Qiu C; Biswas N; Jin J; Watkins SC; Montelaro RC; Coyne CB; Wang T
J Biol Chem; 2008 Mar; 283(13):8643-53. PubMed ID: 18211898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
